What is hyperbaric oxygen therapy (HBOT), and what is it used for?

In hyperbaric oxygen therapy, a person breathes pure oxygen inside a chamber pressurized above normal air pressure. The Undersea and Hyperbaric Medical Society recognizes 15 uses, including decompression sickness, carbon monoxide poisoning, some non-healing diabetic foot wounds, delayed radiation injury and sudden hearing loss. Hyperbaric chambers are FDA-regulated medical devices; clearance covers specific products and uses, not every use offered.
On this page
- Overview
- Why people use it
- Evidence
- Potential benefits
- Risks and side effects
- Who should not have hyperbaric oxygen therapy?
- Administration methods
- How are soft "mild" hyperbaric chambers different from medical HBOT?
- How long does a hyperbaric oxygen therapy session take?
- How long until results?
- How much does hyperbaric oxygen therapy cost (per session)?
- Does insurance or Medicare cover hyperbaric oxygen therapy?
- Which conditions do hyperbaric chamber clearances cover?
- What should I ask a provider before starting hyperbaric oxygen therapy?
- Frequently asked questions
- Provider directory
- References
- Page information
Overview
In hyperbaric oxygen therapy, a person breathes pure oxygen inside a chamber pressurized above normal air pressure.[1][2] The Undersea and Hyperbaric Medical Society recognizes 15 uses, including decompression sickness, carbon monoxide poisoning, some non-healing diabetic foot wounds, delayed radiation injury and sudden hearing loss.[3] Sudden hearing loss appears on UHMS's list and as an option on a US ear, nose and throat guideline, but is not on Medicare's covered list; thermal burns appear on UHMS's list but not on Medicare's. The strength of the evidence varies a great deal by condition: some results come from Cochrane reviews of randomized trials, and others come from small trials that disagree or from trials whose conflict statements list authors who work for or hold a financial stake in a company, AVIV Scientific.
Why people use it
None of the cleared indications we reviewed for hyperbaric chambers covers slowing aging, longevity or general wellness. They name specific conditions, such as carbon monoxide poisoning, decompression sickness or acute mountain sickness (checked September 28, 2026).
The Undersea and Hyperbaric Medical Society's list of 15 recognized medical uses includes decompression sickness, carbon monoxide poisoning, some non-healing diabetic foot wounds and delayed radiation injury. The society's criteria for listing a use include a sound physiologic rationale and extensive clinical experience, so a listing is not a grade of the evidence.[3]
Researchers have also tested hyperbaric oxygen for purposes outside that list, including autism, long COVID, sports recovery and thinking and fitness in healthy older adults.
Evidence
Hyperbaric chambers are FDA-regulated medical devices; clearance covers specific products and uses, not every use offered.
Evidence levels in this table follow our grading key. Established means consistent results from randomized trials, a systematic review of them, or guideline, coverage-policy or regulatory content. Emerging means some controlled human evidence that falls short of that, such as small or mixed trials, or evidence capped by company funding. Experimental means no controlled human evidence for the claim, only uncontrolled or non-randomized studies, blood or index measures, or animal and laboratory work. Not graded means we did not search for later studies of the claim or could not read the key source, and the cell says which. Where a cell says a search found no trial, it names the databases and the date; that is a search result and does not show that no trial exists.
| Why people use it | Who was studied | Evidence level | Main source cited |
|---|---|---|---|
| Diabetic foot ulcers | Adults with diabetic foot ulcers | Emerging (mixed across reviews and trials) | Kranke 2015 Cochrane review; Löndahl 2010, Fedorko 2016 and Santema 2018 trials |
| Sudden hearing loss | Adults with acute sudden sensorineural hearing loss | Emerging (small, low-quality trials; pooled results favored hyperbaric oxygen on some hearing measures, and the clinical significance is unclear) | Bennett 2012 Cochrane review; Joshua 2022 meta-analysis |
| Late radiation injury | People with, or at risk of, late tissue injury after cancer radiotherapy | Emerging (low- to moderate-certainty Cochrane evidence; small trials) | Lin 2023 Cochrane review |
| Carbon monoxide poisoning | Adults with acute carbon monoxide poisoning | Emerging (mixed: in the 2011 Cochrane review, two of six trials found a benefit and both were stopped early; the pooled estimate is not significant) | Buckley 2011 Cochrane review; Weaver 2002 trial |
| Cognition and fitness in healthy older adults | Independently living adults 64 and older in one Israeli trial | Emerging (one small open-label trial without a sham chamber; several authors work for or hold a financial stake in a company, AVIV Scientific, named in the papers' conflict statements) | Hadanny 2020 and Hadanny 2024 (the 2024 paper prints trial registration number NCT02790541; the 2020 paper prints none) |
| Autism | Children and adolescents with autism spectrum disorder | Emerging (mixed: a 2016 Cochrane review found no benefit in its one sham-controlled trial; a 2025 pooled analysis of 17 studies reported improvement and rated its studies poor in quality) | Xiong 2016 Cochrane review; Tu 2025 meta-analysis; Rossignol 2009 trial |
| Long COVID | Adults with post-COVID condition | Emerging (mixed: of three placebo-controlled trials we read, one was positive, and its conflict statement lists authors who work for or hold shares in a company, AVIV Scientific; the other two found no benefit) | Zilberman-Itskovich 2022; Kjellberg 2025 (HOT-LoCO); D'hoore 2025 |
| Sports recovery | Volunteers and athletes with exercise-induced muscle soreness or muscle injury; people with ankle sprain or knee ligament injury; physically active healthy adults | Emerging (mixed) for muscle soreness. A pooled analysis of four small trials in healthy male volunteers in the 2005 review found more pain with hyperbaric oxygen at 48 and 72 hours. A 2026 review found no significant overall benefit, and its abstract reports less soreness in some subgroups and one subgroup interval pointing the other way. Not graded for ankle sprain and knee ligament injury. Two small trials in the 2005 review found no significant difference in the outcomes its abstract reports, and its full text reports two secondary results that favored hyperbaric oxygen; we did not search for later trials. Not graded for recovery from muscle injury. A 2026 review reported faster recovery on a measure we could not read. | Bennett 2005 Cochrane review; Luo 2026 meta-analysis; Huang 2021 meta-analysis |
| Slowing aging or extending life | 110 people of different age groups in one Russian comparative study, and 320 men aged 35 to 92 with illnesses of several organs in another | Experimental (a biological age index in two comparative studies with no random assignment described, read as abstracts only; our searches of PubMed, Europe PMC and ClinicalTrials.gov on 2026-10-01 found no randomized trial reporting a biological age score or a length-of-life result in people without a diagnosed condition; the registered trial NCT05297019 had posted no results as of 2026-10-01) | Gerasimenko 2014; Myakotnykh 2016; ClinicalTrials.gov NCT05297019; our searches, 2026-10-01 |
Diabetic foot ulcers
A 2015 Cochrane review of hyperbaric oxygen for chronic wounds, including 10 trials in 531 people with diabetic foot ulcers, found faster healing of those ulcers at 6 weeks in a pooled analysis of 5 trials (205 people) with hyperbaric oxygen added to standard wound care.[4] In the 2015 Cochrane review of hyperbaric oxygen for chronic wounds, the healing benefit in diabetic foot ulcers was not evident at one year, and the review authors said flaws in the trials meant they were not confident in the results.[4] Three individual trials that we read disagree: one blinded trial found more ulcers healed at one year with hyperbaric oxygen (52% versus 29%), one blinded trial found no difference between hyperbaric oxygen and a sham treatment, and one trial without a sham treatment found no difference in healing or limb salvage in people with poor blood flow to the leg.[5][6][7] The same Cochrane review found no statistically significant difference in the rate of major amputation with hyperbaric oxygen.[4] That Cochrane review carries a 2020 notice from its editors that it was found, after publication, to be noncompliant with Cochrane's conflict-of-interest policy, and that its lead author had declared paid consultancy for drug and infusion companies unrelated to hyperbaric chamber makers.[4] For diabetic foot ulcers, the evidence on healing and on preventing amputation is rated Emerging: results are mixed across reviews and trials, and the two blinded trials described here disagree.
Sudden hearing loss
A 2012 Cochrane review of 7 trials in 392 people with sudden sensorineural hearing loss pooled data from 2 of those trials (114 people) and found that adding hyperbaric oxygen to standard treatment significantly increased the chance of a 25% improvement in average hearing threshold, but not the chance of a 50% improvement.[8] The review's authors wrote that the clinical significance of the improvement remains unclear and that the studies were small and of generally poor quality.[8] A 2022 review of 3 randomized trials in 150 people found an average hearing gain of about 10 decibels when hyperbaric oxygen was added to medical therapy, compared with medical therapy alone.[9] A 2019 US ear, nose and throat guideline lists hyperbaric oxygen, combined with steroid treatment, as an option within two weeks of sudden hearing loss, and as a salvage option within one month if the first treatment did not work.[10] The 2012 Cochrane review of hyperbaric oxygen for sudden hearing loss and tinnitus found no evidence of benefit for hearing loss or tinnitus that had become chronic, and its authors state that they do not recommend using it for chronic hearing loss or tinnitus.[8] The review could not assess the effect of hyperbaric oxygen on tinnitus by pooled analysis.[8] For tinnitus that presented within two weeks, the review reports some indication from methodologically poor studies that hyperbaric oxygen might improve it, and no evidence that any improvement is functionally important.[8]
Does HBOT help late radiation injury after cancer treatment?
A 2023 Cochrane review of 18 studies in 1,071 people with late tissue injury from cancer radiotherapy found, in a pooled analysis of 5 of those trials (468 people), that hyperbaric oxygen was linked to more complete healing or improvement, based on low-certainty evidence.[11] The same review found that hyperbaric oxygen may not prevent death within one year in this group, based on low-certainty evidence from small trials.[11]
In one trial that randomized 144 people who needed dental surgery on a lower jaw previously treated with radiotherapy, and analyzed the main result in 100 of them, 30 daily hyperbaric oxygen sessions did not lower the rate of radiation bone damage (osteoradionecrosis) 6 months after surgery: 6.4% with hyperbaric oxygen versus 5.7% without.[12] An earlier randomized trial in people at high risk who needed teeth removed from an irradiated lower jaw (Marx 1985) reported osteoradionecrosis in 5.4% of those given hyperbaric oxygen first and 29.9% of those given penicillin.[13] We read only its abstract, which does not give the number of participants or the funding.
In two small trials pooled together, in people having surgery to remove jaw bone damaged by radiotherapy, 70% (21 of 30) healed at one year with 30 sessions before and 10 after surgery, compared with 51% (18 of 35) with standard care.[14] In that pooled analysis of two small trials in people having surgery for radiotherapy-damaged jaw bone, the authors said the difference in healing at one year was not statistically significant and that the trials were too small to rule out a real effect.[14]
Does HBOT prevent lasting brain effects after carbon monoxide poisoning?
A Cochrane review of 6 trials in 1,361 people with carbon monoxide poisoning found the trials do not settle whether hyperbaric oxygen prevents lasting brain or thinking problems, and noted that the two trials that did find a benefit were stopped early, which likely inflated their results.[15] One of the trials in that review, of 152 people given three hyperbaric oxygen sessions in 24 hours, found fewer cognitive problems at 6 weeks (25% versus 46%) and at 12 months than with normal-pressure oxygen.[16]
Potential benefits
None of the cleared indications we reviewed for hyperbaric chambers covers slowing aging, longevity or general wellness. They name specific conditions, such as carbon monoxide poisoning, decompression sickness or acute mountain sickness (checked September 28, 2026).
Aging, telomeres, memory and thinking
The telomere, thinking and fitness results in healthy older adults described on this page come from one Israeli trial that enrolled 70 independently living adults aged 64 and older, 63 of whom completed it. The trial had no placebo chamber, and its results have been published in several papers, including the three this page describes.[17][18][19] In that trial's telomere report, only people who received hyperbaric oxygen were studied, with no comparison group: 35 were assigned to hyperbaric oxygen, 30 completed the course, and telomere length was analyzed in 26. The paper's authors concluded that the therapy may lengthen telomeres and clear senescent cells.[20] The same report found fewer senescent immune cells after hyperbaric oxygen in the 20 people analyzed, again without a comparison group.[20] Telomere length and senescent cell counts are blood measurements, not health outcomes. In the same trial, a separate paper found improved cognitive test scores in the group that received hyperbaric oxygen compared with a group that received no intervention, but the study had no sham chamber and only the people scoring the tests were kept unaware of who had been treated.[18] A third paper from the same trial found a small improvement in aerobic fitness (VO2max) in the group that received hyperbaric oxygen, again against a no-intervention control group rather than a sham.[19] The three papers described here from the Israeli trial of adults aged 64 and older (the telomere, cognition and fitness reports) state that they were funded by a research grant from the Sagol network for neuroscience or by the research fund of Shamir Medical Center, and several of their authors work for or hold a financial stake in a company, AVIV Scientific, named in the papers' conflict statements.
In searches of PubMed and Europe PMC on October 1, 2026, we found no controlled study by another research group that measured telomere length or senescent immune cells after a course of hyperbaric oxygen therapy sessions. A 2011 study that followed divers exposed to hyperbaric oxygen and an age-matched comparison group for 12 months (Shlush 2011) reported longer telomeres in two types of white blood cell in the divers, and mildly longer telomeres in one of those cell types in the comparison group as well.[21] We read only its abstract. It studied diving exposure and did not test therapy sessions.
In searches of PubMed, Europe PMC and ClinicalTrials.gov on October 1, 2026, we found no randomized trial in people without a diagnosed condition that reported an effect of hyperbaric oxygen therapy on a biological age score, such as an epigenetic clock or a composite index, or on length of life. That result does not cover telomere length or senescent cell counts, which this page reports separately as blood measurements. Two Russian studies compared hyperbaric oxygen with other treatments, such as dry carbon dioxide baths, and reported effects on a biological age index. One, in 110 people of different age groups (Myakotnykh 2016), described a positive influence of hyperbaric oxygen and of carbon dioxide baths on the index, along with safety limitations and contraindications.[22] The other, in 320 men aged 35 to 92 with illnesses of several organs (Gerasimenko 2014), reported an effect of gas treatments as a group, which included hyperbaric oxygen.[23] We read only their English abstracts, which describe no random assignment, give no figures for the index, and do not say how biological age was measured or who funded the work.
A randomized study of two hyperbaric oxygen pressures and epigenetic age, in adults aged 40 to 70 and open to healthy volunteers, was registered on ClinicalTrials.gov in 2022 (NCT05297019; the registry lists its sponsor, TruDiagnostic, as industry). As of October 1, 2026, the registry record showed an unknown status and no posted results, and a Europe PMC search for the registration number found no published report.[24] Trials in people with a serious illness or injury have counted deaths, including the radiation-injury trials described above. Those results are about survival with that condition and do not show whether hyperbaric oxygen changes length of life in people without it.
Does HBOT help autism or long COVID?
A 2016 Cochrane review included one trial, in which 60 children with autism spectrum disorder were randomly given hyperbaric oxygen or a sham treatment. It reported no improvement in social interaction, communication, behavior or thinking skills, and more side effects with hyperbaric oxygen, mainly minor ear injuries from pressure.[25] A 2025 review pooled 17 studies in 890 children and adolescents with autism (Tu 2025), both randomized and non-randomized, and reported lower symptom scores with hyperbaric oxygen.[26] Its authors described the included studies as poor in quality and highly varied. We read only its abstract and its PubMed record, which carries the authors' statement that they have no known competing interests. An earlier trial randomized 62 children with autism aged 2 to 7 to 40 one-hour sessions at 1.3 atmospheres and 24% oxygen or to slightly pressurized room air, and analyzed 56 of them (Rossignol 2009).[27] It reported better physician-rated scores for overall functioning in the treated group. Changes in total and subscale scores on a behavior checklist were similar between the two groups, except that more children in the treated group improved on irritability. That pressure and oxygen level are lower than in the hyperbaric oxygen therapy this page describes. The study was funded by the International Hyperbarics Association, and eight of its eleven authors reported earning income from hyperbaric treatment in their practices.
Three placebo-controlled trials of hyperbaric oxygen for long COVID that we read disagree: one 40-session trial, whose conflict statement lists two authors as working for a company, AVIV Scientific, and one as a shareholder in it, found improved cognitive test scores, and two 10-session trials, in which no author reported such a link, found no benefit over a placebo treatment.[28][29][30]
Does HBOT speed recovery from sports injuries or muscle soreness?
A 2005 Cochrane review of 9 small trials in 219 people reported, in its abstract, no significant difference in time to recovery, functional outcomes, pain or swelling in one trial of ankle sprain, and no difference in knee function scores in one trial of knee ligament injury.[31] Its full text also reports two secondary results that favored hyperbaric oxygen, one from each trial: a larger improvement in an ankle function score, which the review says should be interpreted cautiously because the scale has not been validated, and better knee pain scores at two weeks.[31] The knee trial did not state how many people were in each group, so the review assumed seven per group, and the two-week pain result was no longer significant when it assumed eight in the hyperbaric group and six in the comparison group.[31] In a pooled analysis of four of its seven trials of exercise-induced muscle soreness, which used the groups given hyperbaric oxygen right away after exercise, healthy male volunteers given it reported more pain than the comparison groups, by about 0.9 points at 48 hours and 0.7 points at 72 hours on a 0 to 10 scale (92 volunteers analyzed).[31] The difference at 24 hours was not significant.[31] Of the other three soreness trials, one reported no difference in soreness at 24, 48 or 72 hours (a raw difference at 72 hours was no longer significant after correction for testing several outcomes).[31] Another reported soreness back to baseline by day three in the hyperbaric group while it was still raised in the comparison group, with apparently no significant difference in its overall results over time.[31] For the third, the review found the pain results unclear and incomplete, so it could not confirm that trial's report of enhanced recovery for pain sensation with hyperbaric oxygen.[31] The review's authors concluded that the evidence was insufficient to establish the effects of hyperbaric oxygen on these injuries.[31] The review called the clinical significance of the modest pain differences unclear.[31]
A 2026 review included 10 randomized trials in 299 people (Luo 2026).[32] It found no significant overall benefit of hyperbaric oxygen for exercise-induced muscle soreness. Its abstract reports significantly less soreness with sessions above 2.0 atmospheres absolute and with 100-minute sessions, and no significant effect with 60-minute sessions. The abstract also lists sessions at 2.0 atmospheres absolute or below as reducing soreness, but the interval it prints for that subgroup lies on the opposite side of zero from the other two, so the direction of that result is unclear. Its authors also reported faster recovery on a muscle-injury measure that the abstract does not name. We read only the abstract, which does not say how many of the trials contributed to each result, how that measure was taken or who funded the review.
A 2021 review of 10 studies in 166 physically active healthy adults (Huang 2021) pooled six of them, in 69 people, across several outcomes, with some analyses covering fewer studies, and found no significant effect of hyperbaric oxygen given before exercise on performance, or given after exercise on recovery.[33] Its authors wrote that hyperbaric oxygen during exercise could improve muscle endurance performance, based on studies they could not pool, and that this needs to be confirmed. Most of the studies had 20 or fewer participants, and 149 of the 166 participants were men. The review was funded by a Chinese national research program and a university laboratory in Shanghai.
Risks and side effects
A 2017 review describes middle ear barotrauma, injury from pressure changes in the ear, as one of the most common side effects of hyperbaric oxygen.[34] A Cochrane review of radiation-injury trials found ear barotrauma far more likely with hyperbaric oxygen than with no pressurization, and not more likely when the comparison group also received a sham pressurization.[11] In a review of over 18,000 treated patients, about 15% had an ear-related (otologic) adverse event, and reported barotrauma incidence in the wider literature ranges from about 2% to 84%, depending on the population and how it was measured.[35][34] A Cochrane review of radiation-injury trials found temporary reduced visual acuity was also more likely with hyperbaric oxygen than without it; a separate review reports that this short-sightedness has been seen in 25% to 100% of people after several weeks of daily treatment, and that it usually reverses within 3 to 6 weeks after treatment stops, though it can take as long as 6 to 12 months.[11][34] Oxygen-toxicity seizures are rare: older estimates put the rate near 1 in 10,000 treatment sessions, and more recent evidence puts it closer to 1 in 2,000 to 3,000 sessions; one large single-center study of over 62,000 sessions found a seizure rate of about 1 in 8,945 sessions.[34][36] Confinement anxiety is reported in about 8 of every 10,000 treatments in single-person chambers, and lung oxygen toxicity is not expected from routine daily sessions.[34]
| Risk | How often reported | Main source cited |
|---|---|---|
| Ear and sinus barotrauma | About 15% had an ear-related (otologic) adverse event; reported barotrauma incidence ranges from about 2% to 84% | Lin 2023 Cochrane review; Voigt 2025; Heyboer 2017 |
| Temporary vision changes | Seen in 25% to 100% of people after several weeks of daily treatment | Lin 2023 Cochrane review; Heyboer 2017 |
| Oxygen-toxicity seizures | About 1 in 10,000 treatments by older estimates, closer to 1 in 2,000 to 3,000 in more recent evidence; about 1 in 8,945 sessions in one large single-center study | Heyboer 2017; Hadanny 2016 (62,614 sessions) |
| Confinement anxiety | About 8 events per 10,000 treatments (monoplace chambers) | Heyboer 2017 |
| Fire | Not established | FDA letter, August 2025; FDA consumer page, 2021 (archived)[2][37] |
In this table, Not established means the sources cited in that row describe the risk but do not give a rate. Rates in this table come from different studies, settings and ways of measuring, and are not directly comparable across rows.
Fire risk
In 'Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices - Letter to Health Care Providers' (August 25, 2025), FDA said it 'is aware of reports of serious injuries and deaths with use of HBOT devices' and that 'While the FDA believes that serious adverse events associated with HBOT devices are rare, health care providers and users should be aware that these events can and do occur and should follow the manufacturer's instructions to help reduce potential risks.' FDA letter to health care providers
In 'Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices - Letter to Health Care Providers' (August 25, 2025), FDA told providers and facilities: 'Be aware that there is a heightened risk of fire with use of oxygen at a high concentration.'
FDA's page 'Hyperbaric Oxygen Therapy: Get the Facts' (FDA page content current as of July 26, 2021; no longer on FDA's website; archived copy, January 2, 2025) said: 'When HBOT chambers are used for indications cleared by the FDA, HBOT is generally safe, and serious complications are rare.' It listed potential risks including 'Ear and sinus pain', 'Middle ear injuries, including tympanic membrane rupture', 'Temporary vision changes' and 'Lung collapse (rare)'. Archived copy of FDA's 2021 page
If you have severe symptoms, call 911 or seek emergency care. Report side effects to FDA MedWatch.
Who should not have hyperbaric oxygen therapy?
An untreated collapsed lung is considered an absolute contraindication, because the pressure changes during treatment could worsen it.[34] A StatPearls reference chapter, last updated in May 2025, also lists an untreated collapsed lung (pneumothorax) as an absolute contraindication.[38] The chapter calls chronic obstructive pulmonary disease, uncontrolled high fever (above 39 °C) and a past spontaneous collapsed lung relative contraindications, and says pregnancy has traditionally been considered one.[38] According to the chapter, active upper respiratory tract infections and severe sinus infections increase the risk of pressure injury to the sinuses and inner ear, claustrophobia may be a contraindication depending on how severe it is, and implanted devices should be pressure-tested to make sure they work under high pressure.[38] It also flags some medicines: using doxorubicin at the same time may increase its risk of heart damage, disulfiram may increase the risk of oxygen toxicity, and cisplatin is a relative contraindication because it may impair wound healing.[38]
This list is not complete, and a licensed clinician should assess anyone's personal risk before treatment.
Administration methods
According to the Undersea and Hyperbaric Medical Society, clinical treatment is given in either a single-person (monoplace) chamber or a multi-person (multiplace) chamber.[3] In a single-person chamber, the whole chamber can be filled with near-100% oxygen that the patient breathes directly, or with compressed air while the patient breathes oxygen through a mask or hood.[3] In a multi-person chamber, the room is filled with compressed air and patients breathe near-100% oxygen through masks, head hoods or breathing tubes.[3]
According to the society, most conditions it recognizes are treated with a series of planned daily sessions over four to eight weeks, while some emergencies are treated once or over a few days, and a few emergencies need more than one session a day.[3]
In one trial in adults with diabetic foot ulcers, each session had 5 minutes of pressurization breathing air, 85 minutes at 2.5 ATA and 5 minutes of depressurization, in a multi-person chamber where the study gas was given by mask.[5]
How are soft "mild" hyperbaric chambers different from medical HBOT?
The Undersea and Hyperbaric Medical Society said, in a position statement revised in 2018, that it was not aware of any reliable clinical evidence that mild pressure below 1.4 atmospheres has any therapeutic effect, and that it does not recommend mild hyperbaric therapy for any medical purpose other than acute mountain sickness.[39] The same society also says it does not endorse home hyperbaric therapy at any time, and that low-pressure air chambers deliver no more oxygen to the body than breathing oxygen through a mask at normal sea-level pressure.[39] A 2009 autism trial at 1.3 atmospheres is described under autism.
How are home soft chambers different from clinical hyperbaric oxygen therapy?
The soft, low-pressure fabric chambers marketed for sports and alternative medicine, which some people buy for home use, operate at less than 1.4 atmospheres, are designed to be filled with air only, and do not meet the Undersea and Hyperbaric Medical Society's definition of clinical hyperbaric oxygen therapy.[39][3]
The Undersea and Hyperbaric Medical Society's 2023 indications manual says many people buy mild hyperbaric chambers for their home with no guidance on the potential for catastrophic events, and warns that when oxygen concentrators are added, oxygen leaking into a chamber at 23.5% or higher may have potential catastrophic results, because oxygen makes fire more intense and faster to spread.[3]
Based on the sources we read, hyperbaric oxygen therapy as the Undersea and Hyperbaric Medical Society defines it takes place in a hard-sided chamber built to national pressure-vessel and fire-safety standards, under a physician's oversight with trained staff monitoring each session, and the society does not endorse home therapy at any time.[3][40][39]
The Undersea and Hyperbaric Medical Society's 2023 indications manual says mild hyperbaric sessions typically last an hour or less, and that treating the conditions hyperbaric oxygen is accepted for in mild chambers is inadequate and ineffective.[3]
We did not find a pressure of 1.3 atmospheres for soft chambers in the society documents we read; the Undersea and Hyperbaric Medical Society describes soft chambers as operating at less than 1.4 atmospheres.[39][3]
How long does a hyperbaric oxygen therapy session take?
According to the Undersea and Hyperbaric Medical Society, medical hyperbaric oxygen sessions typically run 90 to 120 minutes, under a physician's prescription and oversight; the society's own documents give two different pressure thresholds for what counts as medical hyperbaric oxygen, 1.4 atmospheres in one place and 2.0 atmospheres in another, so no single figure can be stated as the standard.[3][39] The Undersea and Hyperbaric Medical Society's 2023 indications manual gives 2.0 to 3.0 atmospheres absolute (ATA) as the most common clinical treatment pressures, with the pressure for each treatment set by the guideline for that condition in the manual.[3]
The society's 2025 guidance for patients says treatment must be supervised by a physician actively involved in the patient's care, and that patients must be continuously watched and listened to by trained staff throughout each session.[40] The Undersea and Hyperbaric Medical Society's 2025 patient guidance says clothing must be issued by the facility or approved by its hyperbaric safety coordinator; 100% cotton and cotton/polyester blends are allowed, with no more than 50% polyester in a single-person chamber, and silk, wool and synthetic fabrics stay out of the chamber unless the hyperbaric physician and safety coordinator approve them.[40] The Undersea and Hyperbaric Medical Society's 2025 patient guidance says any electrical or static-generating device must be kept out of the chamber, products that give off flammable vapors must be excluded, and patients in single-person chambers using 100% oxygen should wear grounding straps to eliminate static discharge risks.[40] Before each treatment, the Undersea and Hyperbaric Medical Society's 2025 patient guidance calls for a safety time-out to confirm the patient's identity, treatment plan and readiness.[40]
We did not read the fire-safety code for hyperbaric facilities, NFPA 99, so this page does not list every item a facility may prohibit; ask the facility what to wear and what to leave behind before the first session.
Whether hyperbaric oxygen therapy may be appropriate for a specific person is decided by a licensed clinician.
Before you schedule, ask the facility what it requires, including whether it needs a referral or an order from your clinician.
How long until results?
The studies cited on this page, as far as we read them (full texts for some and abstracts only for others), do not state how soon a person will notice results from hyperbaric oxygen. They report when outcomes were measured, which ranged from right after a session to one year later, depending on the condition.
In adults with diabetic foot ulcers, individual trials measured their main result at 12 weeks in one trial and at one year in two others.[5][6][7]
In the 2002 trial of hyperbaric oxygen for acute carbon monoxide poisoning, thinking and memory were tested right after the first and third sessions, and again 2 weeks, 6 weeks, 6 months and 12 months after enrollment.[16]
For sudden hearing loss, the 2019 US guideline's timing is about when to start: within 2 weeks of the hearing loss, or within 1 month as a salvage option; we did not read how many sessions the trials behind it used.[10]
| Condition and study | Sessions used | Pressure and session length | When results were measured |
|---|---|---|---|
| Diabetic foot ulcers (2010 trial) | 40 sessions, 5 days a week for 8 weeks[5] | 2.5 ATA, 85 minutes | During treatment, then every 3 months; main result at 1 year |
| Diabetic foot ulcers (2016 trial) | 30 daily sessions[6] | 244 kPa, 90 minutes | 12 weeks after randomization |
| Carbon monoxide poisoning (2002 trial) | 3 sessions within 24 hours[16] | Not in the abstract we read | After sessions 1 and 3, then at 2 weeks, 6 weeks, 6 months and 12 months |
| Dental surgery on an irradiated jaw (2019 trial) | 30 daily sessions at 100% oxygen[12] | 2.4 ATA, 80 to 90 minutes | 6 months after surgery |
| Jaw-bone radiation injury with surgery (2022 pooled trials) | 30 before and 10 after surgery[14] | 243 kPa, 90 minutes | 1 year after surgery |
| Healthy adults 64 and older (one trial) | 60 daily sessions, 5 a week over about 3 months[20] | 2 ATA, 90 minutes with 5-minute air breaks every 20 minutes | Blood samples at the start, at the 30th and 60th sessions, and 1 to 2 weeks after the last session |
Sessions, pressures and timings are what each study used, not a recommended course for any person; several of these trials found no benefit from hyperbaric oxygen, so a course length says nothing about whether the treatment works.
In this table, ATA means atmospheres absolute and kPa means kilopascals; 1 ATA is about 101 kPa, and each pressure is shown in the unit the study reported.
The three papers described here from the Israeli trial of adults aged 64 and older (the telomere, cognition and fitness reports) state that they were funded by a research grant from the Sagol network for neuroscience or by the research fund of Shamir Medical Center, and several of their authors work for or hold a financial stake in a company, AVIV Scientific, named in the papers' conflict statements.
How much does hyperbaric oxygen therapy cost (per session)?
We do not list prices for hyperbaric oxygen therapy on this page yet. Prices vary by facility.
What a facility charges can depend on the type of chamber and setting, how many sessions are ordered, what each session includes, and whether insurance applies.
Ask each facility what its price includes and whether it is charged per session or for a set number of sessions.
To browse providers in the Recovery & performance category, go to Provider directory.
Does insurance or Medicare cover hyperbaric oxygen therapy?
Coverage varies by plan and can depend on the reason it is ordered. Confirm coverage, and any prior authorization, with your insurer.
When we checked on September 30, 2026, Medicare's national coverage policy for hyperbaric oxygen (National Coverage Determination 20.29, version 4, in effect since April 3, 2017) listed 15 covered conditions.[41] Among the 15 covered conditions in Medicare's National Coverage Determination 20.29 are acute carbon monoxide poisoning, decompression illness, gas embolism, gas gangrene, cyanide poisoning, radiation damage to bone or soft tissue as an add-on to standard treatment, long-lasting bone infection that has not responded to standard medical and surgical treatment, and some diabetic wounds of the lower limbs.[41]
For diabetic wounds, the policy requires type 1 or type 2 diabetes with a lower-limb wound caused by diabetes, a wound of Wagner grade III or higher, and a failed adequate course of standard wound care, and it lists hyperbaric oxygen as covered only as an add-on after at least 30 days of standard wound care with no measurable signs of healing.[41]
The policy also requires the wound to be evaluated at least every 30 days during treatment, and says continued hyperbaric oxygen is not covered if measurable signs of healing have not been shown within any 30-day period.[41]
Medicare's National Coverage Determination 20.29 says no Medicare payment may be made for conditions not on its list.[41] National Coverage Determination 20.29 names 22 conditions it does not cover, including thermal skin burns, cutaneous, decubitus and stasis ulcers, multiple sclerosis, arthritic diseases, senility, and nonvascular causes of chronic brain syndrome (Pick's disease, Alzheimer's disease, Korsakoff's disease).[41]
The policy does not state a number of sessions, a session length or a treatment pressure.[41]
Questions to ask your insurer include whether the reason your clinician orders the treatment is covered, whether prior authorization is needed, and whether the facility is in your plan's network.
Which conditions do hyperbaric chamber clearances cover?
Hyperbaric chambers are FDA-regulated medical devices; clearance covers specific products and uses, not every use offered.
Hyperbaric chambers are regulated by FDA as medical devices (Class II). The FESL, FEDL and FETL FINK Chambers (Fink Engineering, K240569) were cleared through FDA's 510(k) process for prescription use for 'The conditions listed as appropriate for the use of HBO recognized by the Undersea & Hyperbaric Medical Society's (UHMS) Hyperbaric Oxygen Therapy Committee Report'. The clearance lists 13 conditions, including 'Air or gas embolism', 'Carbon monoxide poisoning and carbon monoxide poisoning complicated by cyanide poisoning' and 'Decompression sickness'.
Hyperbaric chambers are regulated by FDA as medical devices (Class II). The Revitalair 430F portable hyperbaric chamber (Oxavita S.R.L., K171899) was cleared through FDA's 510(k) process for prescription use: 'to treat acute mountain sickness under the prescription of a health professional. The medical device is designed for use at physician offices and health institutions.'
Do you need a prescription for hyperbaric oxygen therapy?
| Device | FDA record | Class | Cleared indication | Type of use | Decision date |
|---|---|---|---|---|---|
| FESL FINK Chamber; FEDL FINK Chamber; FETL FINK Chamber | K240569 | Class II | The conditions listed as appropriate for the use of HBO recognized by the Undersea & Hyperbaric Medical Society's (UHMS) Hyperbaric Oxygen Therapy Committee Report, as follows: 1. Air or gas embolism 2. Carbon monoxide poisoning and carbon monoxide poisoning complicated by cyanide poisoning 3. Clostridial myonecrosis and myonecrosis 4. Crush injuries, compartment syndrome, and other acute traumatic ischemias 5. Decompression sickness 6. Enhancement of healing of selected problem wounds 7. Exceptional blood loss anemia 8. Necrotizing soft tissue infections 9. Osteomyelitis (refractory) 10. Delayed radiation injuries (soft tissue and bony necrosis) 11. Compromised grafts and flaps 12. Acute Thermal Burn Injury 13. Intracranial abscess | Prescription use | 2024-11-21 |
| Revitalair 430F | K171899 | Class II | The intended use of the Portable Hyperbaric Chamber Revitalair® 430F is to treat acute mountain sickness under the prescription of a health professional. The medical device is designed for use at physician offices and health institutions. | Prescription use | 2019-11-22 |
FDA records we reviewed for hyperbaric chambers, checked September 28, 2026.
| Condition, as FDA listed it in 2021 |
|---|
| Air and gas bubbles in blood vessels |
| Anemia (severe anemia when blood transfusions cannot be used) |
| Burns (severe and large burns treated at a specialized burn center) |
| Carbon monoxide poisoning |
| Crush injury |
| Decompression sickness (diving risk) |
| Gas gangrene |
| Hearing loss (complete hearing loss that occurs suddenly and without any known cause) |
| Infection of the skin and bone (severe) |
| Radiation injury |
| Skin graft flap at risk of tissue death |
| Vision loss (when sudden and painless in one eye due to blockage of blood flow) |
| Wounds (non-healing, diabetic foot ulcers) |
FDA's page 'Hyperbaric Oxygen Therapy: Get the Facts' (FDA page content current as of July 26, 2021; no longer on FDA's website; archived copy, January 2, 2025) said: 'be aware that some claims of what it can do are unproven. For example, HBOT devices are not proven to cure cancer, Lyme disease, autism or Alzheimer's disease.' Archived copy of FDA's 2021 page
Regulatory status checked September 28, 2026. Sources: www.govinfo.gov/…/CFR-2025-title21-vol8-sec868-5470.xml; www.govinfo.gov/…/CFR-2025-title21-vol8-sec807-97.xml; www.accessdata.fda.gov/…/K240569.pdf; www.accessdata.fda.gov/…/K171899.pdf; www.fda.gov/…/follow-instructions-safe-use-hyperbaric-oxygen-therapy-devices-letter-health-care-providers
What should I ask a provider before starting hyperbaric oxygen therapy?
These questions come from the Undersea and Hyperbaric Medical Society's 2025 patient guidance and, for diabetic foot wounds, from Medicare's national coverage policy.[40][41] They are prompts for a conversation with a licensed clinician, and they do not show whether hyperbaric oxygen is appropriate for you.
- Which physician will supervise my treatment, and is that physician actively involved in my care?
- What training in hyperbaric medicine does the supervising physician have?
- How will staff watch and listen to me during each session?
- Is a safety time-out done before each treatment to confirm my identity, my treatment plan and that I am ready?
- Who issues or approves the clothing I wear in the chamber, and which items do I have to leave outside?
- How many sessions are planned for my condition, and what review is done if more than the usual number is proposed?
- If I have a diabetic foot wound, what is its Wagner grade, and how long has it gone without measurable healing on standard wound care?
- How often will my wound be evaluated during treatment, and what happens if it shows no measurable healing?
Frequently asked questions
Does hyperbaric oxygen therapy help diabetic foot ulcers heal?
A 2015 Cochrane review of hyperbaric oxygen for chronic wounds, including 10 trials in 531 people with diabetic foot ulcers, found faster healing of those ulcers at 6 weeks in a pooled analysis of 5 trials (205 people) with hyperbaric oxygen added to standard wound care.[4] In the 2015 Cochrane review of hyperbaric oxygen for chronic wounds, the healing benefit in diabetic foot ulcers was not evident at one year, and the review authors said flaws in the trials meant they were not confident in the results.[4] Three individual trials that we read disagree: one blinded trial found more ulcers healed at one year with hyperbaric oxygen (52% versus 29%), one blinded trial found no difference between hyperbaric oxygen and a sham treatment, and one trial without a sham treatment found no difference in healing or limb salvage in people with poor blood flow to the leg.[5][6][7] The same Cochrane review found no statistically significant difference in the rate of major amputation with hyperbaric oxygen.[4] For diabetic foot ulcers, the evidence on healing and on preventing amputation is rated Emerging: results are mixed across reviews and trials, and the two blinded trials described here disagree.
Can hyperbaric oxygen therapy help sudden hearing loss?
A 2012 Cochrane review of 7 trials in 392 people with sudden sensorineural hearing loss pooled data from 2 of those trials (114 people) and found that adding hyperbaric oxygen to standard treatment significantly increased the chance of a 25% improvement in average hearing threshold, but not the chance of a 50% improvement.[8] The review's authors wrote that the clinical significance of the improvement remains unclear and that the studies were small and of generally poor quality.[8] A 2019 US ear, nose and throat guideline lists hyperbaric oxygen, combined with steroid treatment, as an option within two weeks of sudden hearing loss, and as a salvage option within one month if the first treatment did not work.[10] The 2012 Cochrane review of hyperbaric oxygen for sudden hearing loss and tinnitus found no evidence of benefit for hearing loss or tinnitus that had become chronic, and its authors state that they do not recommend using it for chronic hearing loss or tinnitus.[8] The review could not assess the effect of hyperbaric oxygen on tinnitus by pooled analysis.[8] For tinnitus that presented within two weeks, the review reports some indication from methodologically poor studies that hyperbaric oxygen might improve it, and no evidence that any improvement is functionally important.[8]
Does hyperbaric oxygen therapy slow aging or lengthen telomeres?
The telomere, thinking and fitness results in healthy older adults described on this page come from one Israeli trial that enrolled 70 independently living adults aged 64 and older, 63 of whom completed it. The trial had no placebo chamber, and its results have been published in several papers, including the three this page describes.[17][18][19] The three papers described here from the Israeli trial of adults aged 64 and older (the telomere, cognition and fitness reports) state that they were funded by a research grant from the Sagol network for neuroscience or by the research fund of Shamir Medical Center, and several of their authors work for or hold a financial stake in a company, AVIV Scientific, named in the papers' conflict statements. In searches of PubMed and Europe PMC on October 1, 2026, we found no controlled study by another research group that measured telomere length or senescent immune cells after a course of hyperbaric oxygen therapy sessions. In searches of PubMed, Europe PMC and ClinicalTrials.gov on October 1, 2026, we found no randomized trial in people without a diagnosed condition that reported an effect of hyperbaric oxygen therapy on a biological age score, such as an epigenetic clock or a composite index, or on length of life. That result does not cover telomere length or senescent cell counts, which this page reports separately as blood measurements.
None of the cleared indications we reviewed for hyperbaric chambers covers slowing aging, longevity or general wellness. They name specific conditions, such as carbon monoxide poisoning, decompression sickness or acute mountain sickness (checked September 28, 2026).
What are the side effects of hyperbaric oxygen therapy?
A 2017 review describes middle ear barotrauma, injury from pressure changes in the ear, as one of the most common side effects of hyperbaric oxygen.[34] A Cochrane review of radiation-injury trials found ear barotrauma far more likely with hyperbaric oxygen than with no pressurization, and not more likely when the comparison group also received a sham pressurization.[11] Oxygen-toxicity seizures are rare: older estimates put the rate near 1 in 10,000 treatment sessions, and more recent evidence puts it closer to 1 in 2,000 to 3,000 sessions; one large single-center study of over 62,000 sessions found a seizure rate of about 1 in 8,945 sessions.[34][36]
Provider directory
The link below opens the Recovery & performance category of the provider directory.
None of the cleared indications we reviewed for hyperbaric chambers covers slowing aging, longevity or general wellness. They name specific conditions, such as carbon monoxide poisoning, decompression sickness or acute mountain sickness (checked September 28, 2026).
A licensed clinician decides whether treatment is appropriate. Treatment is not guaranteed.
References
- Code of Federal Regulations. 21 CFR 868.5470, Hyperbaric chamber (eCFR, current). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-21?part=868§ion=868.5470. Accessed 2026-09-28.
- U.S. Food and Drug Administration. Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices: Letter to Health Care Providers. August 25, 2025. https://www.fda.gov/medical-devices/letters-health-care-providers/follow-instructions-safe-use-hyperbaric-oxygen-therapy-devices-letter-health-care-providers. Accessed 2026-10-01.
- Huang ET, ed. UHMS Hyperbaric Medicine Indications Manual. 15th ed. Undersea and Hyperbaric Medical Society / Best Publishing Company; 2023. ISBN 978-1-947239-42-5. https://uhms.org/images/indications/UHMS%20Indications%2015th%20Ed%20Front%20Matter%20and%20References.pdf. Accessed 2026-09-28.
- Kranke P, Bennett MH, Martyn-St James M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;(6):CD004123. PMID 26106870. https://doi.org/10.1002/14651858.CD004123.pub4. Accessed 2026-10-01.
- Löndahl M, Katzman P, Nilsson A, et al. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33(5):998-1003. PMID 20427683. https://doi.org/10.2337/dc09-1754. Accessed 2026-09-28.
- Fedorko L, Bowen JM, Jones W, et al. Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. Diabetes Care. 2016;39(3):392-399. PMID 26740639. https://doi.org/10.2337/dc15-2001. Accessed 2026-10-01.
- Santema KTB, Stoekenbroek RM, Koelemay MJW, et al. Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower-Extremity Ulcers in Patients With Diabetes: Results of the DAMO2CLES Multicenter Randomized Clinical Trial. Diabetes Care. 2018;41(1):112-119. PMID 29074815. https://doi.org/10.2337/dc17-0654. Accessed 2026-10-01.
- Bennett MH, Kertesz T, Perleth M, et al. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev. 2012;10:CD004739. PMID 23076907. https://doi.org/10.1002/14651858.CD004739.pub4. Accessed 2026-10-01.
- Joshua TG, Ayub A, Wijesinghe P, et al. Hyperbaric Oxygen Therapy for Patients With Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2022;148(1):5-11. PMID 34709348. https://doi.org/10.1001/jamaoto.2021.2685. Accessed 2026-10-01.
- Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary. Otolaryngol Head Neck Surg. 2019;161(2):195-210. PMID 31369349. https://doi.org/10.1177/0194599819859883. Accessed 2026-09-28.
- Lin ZC, Bennett MH, Hawkins GC, et al. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2023;8(8):CD005005. PMID 37585677; PMCID PMC10426260. https://doi.org/10.1002/14651858.CD005005.pub5. Accessed 2026-10-01.
- Shaw RJ, Butterworth CJ, Silcocks P, et al. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomized Controlled Trial of Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible After Dentoalveolar Surgery. Int J Radiat Oncol Biol Phys. 2019;104(3):530-539. PMID 30851351. https://pubmed.ncbi.nlm.nih.gov/30851351/. Accessed 2026-10-01.
- Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111(1):49-54. PMID 3897335. https://doi.org/10.14219/jada.archive.1985.0074. Accessed 2026-10-01.
- Forner LE, Dieleman FJ, Shaw RJ, et al. Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1. Radiother Oncol. 2022;166:137-144. PMID 34843843. https://pubmed.ncbi.nlm.nih.gov/34843843/. Accessed 2026-10-01.
- Buckley NA, Juurlink DN, Isbister G, Bennett MH, Lavonas EJ. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev. 2011;(4):CD002041. PMID 21491385. https://doi.org/10.1002/14651858.CD002041.pub3. Accessed 2026-10-01.
- Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002;347(14):1057-1067. PMID 12362006. https://doi.org/10.1056/NEJMoa013121. Accessed 2026-10-01.
- ClinicalTrials.gov. NCT02790541: Changes in Blood Flow and Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy (ANGIOHBOT). Sponsor: Assaf-Harofeh Medical Center. https://clinicaltrials.gov/study/NCT02790541. Accessed 2026-10-01.
- Hadanny A, Daniel-Kotovsky M, Suzin G, et al. Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial. Aging (Albany NY). 2020;12(13):13740-13761. PMID 32589613. https://doi.org/10.18632/aging.103571. Accessed 2026-10-01.
- Hadanny A, Sasson E, Copel L, et al. Physical enhancement of older adults using hyperbaric oxygen: a randomized controlled trial. BMC Geriatr. 2024;24(1):572. PMID 38961397. https://doi.org/10.1186/s12877-024-05146-3. Accessed 2026-10-01.
- Hachmo Y, Hadanny A, Abu Hamed R, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020;12(22):22445-22456. PMID 33206062. https://doi.org/10.18632/aging.202188. Accessed 2026-10-01.
- Shlush LI, Skorecki KL, Itzkovitz S, et al. Telomere elongation followed by telomere length reduction, in leukocytes from divers exposed to intense oxidative stress--implications for tissue and organismal aging. Mech Ageing Dev. 2011;132(3):123-130. PMID 21320523. https://doi.org/10.1016/j.mad.2011.01.005. Accessed 2026-10-01.
- Myakotnykh VS, Torgashov MN, Egorin KV, et al. Comparative analysis of different methods of geroprotective. Adv Gerontol. 2016;29(4):594-601. Article in Russian; English title as given in PubMed. PMID 28539017. https://pubmed.ncbi.nlm.nih.gov/28539017/. Accessed 2026-10-01.
- Gerasimenko EN, Meshchaninov VN, Zvezdina EM, et al. Comparative analysis of gerontologic prophylaxis efficiency and membranotropic action of various gas therapy. Adv Gerontol. 2014;27(3):477-483. Article in Russian; English title as given in PubMed. PMID 25826995. https://pubmed.ncbi.nlm.nih.gov/25826995/. Accessed 2026-10-01.
- ClinicalTrials.gov. NCT05297019: A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging. Sponsor: TruDiagnostic. https://clinicaltrials.gov/study/NCT05297019. Accessed 2026-10-01.
- Xiong T, Chen H, Luo R, et al. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD). Cochrane Database Syst Rev. 2016;10:CD010922. PMID 27737490. https://doi.org/10.1002/14651858.CD010922.pub2. Accessed 2026-10-01.
- Tu P, Halili X, Zhang S, Yang J, Xiao Y. The effectiveness of hyperbaric oxygen therapy in children and adolescents and with autism spectrum disorders: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2025;137:111257. PMID 39826608. https://doi.org/10.1016/j.pnpbp.2025.111257. Accessed 2026-10-01.
- Rossignol DA, Rossignol LW, Smith S, et al. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr. 2009;9:21. PMID 19284641; PMCID PMC2662857. https://doi.org/10.1186/1471-2431-9-21. Accessed 2026-10-01.
- Kjellberg A, Hassler A, Boström E, et al. Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid (HOT-LoCO): a randomised, placebo-controlled, double-blind, phase II trial. BMJ Open. 2025;15(4):e094386. PMID 40228859. https://doi.org/10.1136/bmjopen-2024-094386. Accessed 2026-10-01.
- Zilberman-Itskovich S, Catalogna M, Sasson E, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. 2022;12(1):11252. PMID 35821512. https://doi.org/10.1038/s41598-022-15565-0. Accessed 2026-10-01.
- D'hoore L, Germonpré P, Rinia B, et al. Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial. Diving Hyperb Med. 2025;55(2):104-113. PMID 40544138. https://doi.org/10.28920/dhm55.2.104-113. Accessed 2026-10-01.
- Bennett M, Best TM, Babul S, et al. Hyperbaric oxygen therapy for delayed onset muscle soreness and closed soft tissue injury. Cochrane Database Syst Rev. 2005;(4):CD004713. PMID 16235376. https://doi.org/10.1002/14651858.CD004713.pub2. Accessed 2026-10-01.
- Luo X, Yu Y, Zhang S, Qi F. Effects of Hyperbaric Oxygen Therapy on Exercise-Induced Muscle Injury and Soreness: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil. 2026;107(3):522-532. PMID 40784513. https://doi.org/10.1016/j.apmr.2025.07.017. Accessed 2026-10-01.
- Huang X, Wang R, Zhang Z, Wang G, Gao B. Effects of Pre-, Post- and Intra-Exercise Hyperbaric Oxygen Therapy on Performance and Recovery: A Systematic Review and Meta-Analysis. Front Physiol. 2021;12:791872. PMID 34887780; PMCID PMC8650584. https://doi.org/10.3389/fphys.2021.791872. Accessed 2026-10-01.
- Heyboer M 3rd, Sharma D, Santiago W, et al. Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified. Adv Wound Care (New Rochelle). 2017;6(6):210-224. PMID 28616361. https://doi.org/10.1089/wound.2016.0718. Accessed 2026-10-01.
- Voigt A, Laspro M, Thys E, et al. Systematic Review of Otologic Adverse Events in Hyperbaric Oxygen Therapy. Undersea Hyperb Med. 2025;52(4):537-547. PMID 41429031. https://pubmed.ncbi.nlm.nih.gov/41429031/. Accessed 2026-09-28.
- Hadanny A, Meir O, Bechor Y, et al. Seizures during hyperbaric oxygen therapy: retrospective analysis of 62,614 treatment sessions. Undersea Hyperb Med. 2016;43(1):21-28. PMID 27000010. https://pubmed.ncbi.nlm.nih.gov/27000010/. Accessed 2026-09-28.
- U.S. Food and Drug Administration. Hyperbaric Oxygen Therapy: Get the Facts. Consumer update, content current as of 07/26/2021. No longer on fda.gov. Archived copy: https://web.archive.org/web/20250102110859/https://www.fda.gov/consumers/consumer-updates/hyperbaric-oxygen-therapy-get-facts. Accessed 2026-09-28.
- Gawdi R, Yrastorza J, Cooper JS. Hyperbaric Oxygen Therapy Contraindications. In: StatPearls. Last update May 27, 2025. https://www.ncbi.nlm.nih.gov/books/NBK557661/. Accessed 2026-09-30.
- Bird N; UHMS Safety Committee and Oxygen Therapy Committee. UHMS Position Statement: Low-Pressure Fabric Hyperbaric Chambers. Undersea and Hyperbaric Medical Society. Created January 22, 2017; revised July 10, 2018. https://uhms.org/images/Position-Statements/UHMS_Position_Statement_LP_chambers_revised.pdf. Accessed 2026-09-28.
- Undersea and Hyperbaric Medical Society. Ten Guidelines for Patients and Referring Physicians In Selecting Safe Hyperbaric Oxygen Treatments. Version 4-17-25, April 2025. https://uhms.org/images/Safety-Articles/Hyperbaric%20Safety%20bullet%20%20v4.17.25%20Clean-u.pdf. Accessed 2026-09-30.
- Centers for Medicare & Medicaid Services. National Coverage Determination 20.29: Hyperbaric Oxygen Therapy. Publication 100-3, version 4, effective 04/03/2017. https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=12. Accessed 2026-09-30.